Showing results (121-130 of 403) with videos related to
Sort By:
Pageof 41
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2005
The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-beta signaling by inactivating the TGF-beta type II receptorWook Jin, Byung-Chul Kim, Cristina Tognon, et al.Pediatric Blood & Cancer|February 19, 2010
Initial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the Pediatric Preclinical Testing ProgramPeter J Houghton, Christopher L Morton, Richard Gorlick, et al.Carcinogenesis|December 11, 2012
Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibilityMario Capasso, Sharon J Diskin, Francesca Totaro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2023
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk StratificationHannah G Bender, Meredith S Irwin, Michael D Hogarty, et al.Pediatric Blood & Cancer|October 27, 2023
Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131 I-MIBG in patients with relapsed/refractory neuroblastomaVandana Batra, Ajami Gikandi, Bruce Pawel, et al.Oncogene|April 15, 2005
Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastomaPeter S White, Patricia M Thompson, Takahiro Gotoh, et al.Genome Research|January 15, 2009
Genomic copy number determination in cancer cells from single nucleotide polymorphism microarrays based on quantitative genotyping corrected for aneuploidyEdward F Attiyeh, Sharon J Diskin, Marc A Attiyeh, et al.Pediatric Blood & Cancer|December 19, 2007
Initial testing (stage 1) of the BH3 mimetic ABT-263 by the pediatric preclinical testing programRichard Lock, Hernan Carol, Peter J Houghton, et al.Scientific Data|March 29, 2017
Transcriptomic profiling of 39 commonly-used neuroblastoma cell linesJo Lynne Harenza, Maura A Diamond, Rebecca N Adams, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2007
Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastomaKatherine K Matthay, Gregory Yanik, Julia Messina, et al.Pageof 41